Convalescent plasma does NOT work: Doctors pause trial of drug because no proof it works

Scientists running the REMAP-CAP trial, led by Imperial College London, have stopped enrolling Covid ICU patients after finding 'no evidence' convalescent plasma boosted survival rates.